arrow
T

Tobias Sejbæk

University of Copenhagen
H指数:15
被引数:778

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Between-hospital variation in discontinuation of treatment with dimethyl fumarate in multiple sclerosis

多发性硬化患者二甲双酚酸治疗中止的医院间差异

2026-08-010
PRE
Are exercise booster sessions effective at preserving exercise-induced effects in people with multiple sclerosis? A randomised controlled trial: results from the MSBOOST trial

运动增强干预对维持多发性硬化患者运动诱导效应的效果如何?一项随机对照试验:MSBOOST试验的结果

2026-07-011
PRE
A Phase 4, multicenter, prospective, non-interventional, observational study to investigate the effectiveness and safety/tolerability of perampanel when used as first adjunctive therapy in routine clinical practice in people with epilepsy: Study 512

一项第4期、多中心、前瞻性、非干预性、观察性研究,旨在调查在癫痫患者常规临床实践中,当使用perampanel作为首选用药辅助疗法时的有效性和安全性/耐受性:研究512

2025-04-150
OA
Risk of hypertension in patients with multiple sclerosis treated with teriflunomide compared to dimethyl fumarate: A nationwide cohort study in Denmark

与富马酸二甲酯相比,特利氟米特治疗多发性硬化患者的高血压风险: 丹麦的一项全国性队列研究

2024-12-040
PRE
Patterns and predictors of multiple sclerosis phenotype transition

多发性硬化表型转变的模式和预测因素

2024-11-230
OAAI
Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish study

新诊断的特利氟米特治疗的多发性硬化患者疾病活动的预后因素: 一项全国性的丹麦研究

2024-04-030
PRE
Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine doses
2023-04-257
OAAI
MIF in the cerebrospinal fluid is decreased during relapsing-remitting while increased in secondary progressive multiple sclerosis

复发缓解期间脑脊液中的MIF减少,而继发性进行性多发性硬化症则增加

2022-08-018
PRE
Omics-Based Approach Reveals Complement-Mediated Inflammation in Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS)
2018-04-2310
OAAI